U.S. Markets close in 4 mins

MDT’s Diabetes Business Could Significantly Boost Its Revenue

Daniel Collins
MDT’s Diabetes Business Could Significantly Boost Its Revenue

In fiscal Q4 2018, Medtronic’s (MDT) Diabetes segment generated revenue of $645 million compared to $512 million in fiscal 2017, which reflected a ~26% rise YoY (year-over-year).